Related Experiment Videos
Neonatal presentation of coenzyme Q10 deficiency.
S Rahman1, I Hargreaves, P Clayton
1Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, London, United Kingdom.
The Journal of Pediatrics
|September 20, 2001
Summary
A neonate with ubiquinone deficiency showed low mitochondrial complex II + III activity. Ubiquinone therapy did not improve the condition, and the patient died at age two.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Ubiquinone (Coenzyme Q10) is essential for mitochondrial electron transport.
- Deficiencies can lead to severe multisystem disorders.
- Neonatal presentation of ubiquinone deficiency is rare.
Observation:
- A neonate presented with symptoms suggestive of mitochondrial dysfunction.
- Skeletal muscle biopsy revealed significantly reduced mitochondrial complex II + III activity.
- High-performance liquid chromatography confirmed low ubiquinone levels.
Findings:
- Mitochondrial complex II + III activity was restored in vitro by a ubiquinone analogue.
- Oral ubiquinone supplementation failed to yield clinical improvement.
- The patient experienced a fatal outcome at two years of age.
Implications:
- This case highlights the severe consequences of neonatal ubiquinone deficiency.
- It underscores the challenges in treating mitochondrial disorders with ubiquinone supplementation.
- Further research is needed to understand the pathophysiology and therapeutic strategies for ubiquinone deficiencies.